Evidence map›Paper›PMID 24867716›Full record

ArticlePlastic and reconstructive surgery2014

Engineered nasal cartilage by cell homing: a model for augmentative and reconstructive rhinoplasty.

Avital Mendelson, Jeffrey M Ahn, Kamila Paluch, Mildred C Embree, Jeremy J Mao

Open access · greenAbstract read
In one paragraph

Article in Plastic and reconstructive surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. The current techniques in dorsal augmentation rhinoplasty: a comprehensive review.Maxillofacial plastic and reconstructive surgery · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Clinical Applications for Tissue Engineering in Rhinology.Turkish archives of otorhinolaryngology · 2019
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Avital MendelsonNew York, N.Y. From the Center for Craniofacial Regeneration and the Department of Otolaryngology-Head and Neck Surgery, Columbia University Medical Center; and the Department of Biomedical Engineering, Columbia University.
Jeffrey M Ahn
Kamila Paluch
Mildred C Embree
Jeremy J Mao
Columbia University Irving Medical Center · USColumbia University · US

Funding

Pre-clinical Models of Odontic Analogs by Endogenous Stem CellsR01DE023112 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAO, JEREMY J · 2013 to 2016
$2.9M
Regeneration of Clinically Relevant Orofacial Tissues in Pre-Clinical ModelsRC2DE020767 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAO, JEREMY J · 2009 to 2010
$2.0M
NIBIB NIH HHS R01EB0062621NIDCR NIH HHS R01 DE023112NIDCR NIH HHS RC2 DE020767NIDCR NIH HHS RC2DE020767
6 · The paper itself

Abstract

backgroundCurrent augmentative and reconstructive rhinoplasties use auto logous tissue grafts or synthetic bioinert materials to repair nasal trauma or attain an aesthetic shape. Autologous grafts are associated with donor-site trauma and morbidity. Synthetic materials are widely used but often yield an unnatural appearance and are prone to infection or dislocation. There is an acute clinical need for the generation of native tissues to serve as rhinoplasty grafts without the undesirable features that are associated with autologous grafts or current synthetic materials.

methodsBioactive scaffolds were developed that not only recruited cells in the nasal dorsum in vivo, but also induced chondrogenesis of the recruited cells. Bilayered scaffolds were fabricated with alginate-containing gelatin microspheres encapsulating cytokines atop a porous poly(lactic-co-glycolic acid) base. Microspheres were fabricated to contain recombinant human transforming growth factor-β3 at doses of 200, 500, or 1000 ng, with phosphate-buffered saline-loaded microspheres used as a control. A rat model of augmentation rhinoplasty was created by implanting scaffolds atop the native nasal cartilage surface that was scored to induce cell migration. Tissue formation and chondrogenesis in the scaffolds were evaluated by image analysis and histologic staining with hematoxylin and eosin, toluidine blue, Verhoeff elastic-van Geison, and aggrecan immunohistochemistry.

resultsSustained release of increasing doses of transforming growth factor-β3 for up to the tested 10 weeks promoted orthotopic cartilage-like tissue formation in a dose-dependent manner.

conclusionsThese findings represent the first attempt to engineer cartilage tissue by cell homing for rhinoplasty, and could potentially serve as an alternative material for augmentative and reconstructive rhinoplasty.

Indexed as

Tissue ScaffoldsAnimalsBiocompatible MaterialsCell MovementChondrogenesisCoated Materials, BiocompatibleLactic AcidMesenchymal Stem CellsMicrospheresModels, AnimalNasal CartilagesPlastic Surgery ProceduresPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerRatsRats, Sprague-DawleyBiocompatible MaterialsCoated Materials, BiocompatibleLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerTransforming Growth Factor beta3

Identifiers

PMID24867716
PMCPMC4048865
OpenAlexW1988253121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.